Structural diversity in conserved regions like the DRY-motif among viral 7TM receptors - A consequence of evolutionary pressure?

Advances in Virology

Volumn 2012, Issue , 2012, Pages

  Jensen, Ann Sofie Mølleskov ^a   Sparre Ulrich, Alexander Hovard ^a   Davis Poynter, Nicholas ^b   Rosenkilde, Mette Marie ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES;

EID: 84873854619     PISSN: 16878639     EISSN: 16878647     Source Type: Journal    
DOI: 10.1155/2012/231813     Document Type: Review

References (149)

1. Rosenbaum D. M., Rasmussen S. G. F., Kobilka B. K., The structure and function of G-protein-coupled receptors. Nature 2009 459 7245 356 363 2-s2.0-66249144426 10.1038/nature08144
2. Rajagopal K., Lefkowitz R. J., Rockman H. A., When 7 transmembrane receptors are not G protein-coupled receptors. Journal of Clinical Investigation 2005 115 11 2971 2974 2-s2.0-27644477496 10.1172/JCI26950 (Pubitemid 41567561)
3. Cabrera-Vera T. M., Insights into G protein structure, function, and regulation. Endocrine Reviews 2003 24 6 765 781 (Pubitemid 38067698)
4. Lefkowitz R. J., Seven transmembrane receptors: something old, something new. Acta Physiologica 2007 190 1 9 19 2-s2.0-34147137118 10.1111/j.1365-201X. 2007.01693.x (Pubitemid 46570176)
5. Altenbach C., Kusnetzow A. K., Ernst O. P., Hofmann K. P., Hubbell W. L., High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation. Proceedings of the National Academy of Sciences of the United States of America 2008 105 21 7439 7444 2-s2.0-44949236117 10.1073/pnas.0802515105 (Pubitemid 351830036)
6. Hubbell W. L., Altenbach C., Hubbell C. M., Khorana H. G., Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking. Advances in Protein Chemistry 2003 63 243 290 2-s2.0-0037285444 10.1016/S0065-3233(03)63010-X (Pubitemid 36268430)
7. Schwartz T. W., Frimurer T. M., Holst B., Rosenkilde M. M., Elling C. E., Molecular mechanism of 7tm receptor activation-a global toggle switch model. Annual Review of Pharmacology and Toxicology 2006 46 481 519 2-s2.0-33144459843 10.1146/annurev.pharmtox.46.120604.141218 (Pubitemid 43271198)
8. Schwartz T. W., Locating ligand-binding sites in 7tm receptors by protein engineering. Current Opinion in Biotechnology 1994 5 4 434 444 2-s2.0-0027933763 10.1016/0958-1669(94)90054-X (Pubitemid 24254296)
9. Ballesteros J. A., Weinstein H., Sealfon S. C., Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Receptor molecular biology 1995 New York, NY, USA Academic Press
10. Palczewski K., Kumasaka T., Hori T., Behnke C. A., Motoshima H., Fox B. A., Le Trong I., Teller D. C., Okada T., Stenkamp R. E., Yamamoto M., Miyano M., Crystal structure of rhodopsin: a G protein-coupled receptor. Science 2000 289 5480 739 745 2-s2.0-0034604451 10.1126/science.289.5480.739 (Pubitemid 30650186)
11. Cherezov V., Rosenbaum D. M., Hanson M. A., Rasmussen S. G. F., Foon S. T., Kobilka T. S., Choi H. J., Kuhn P., Weis W. I., Kobilka B. K., Stevens R. C., High-resolution crystal structure of an engineered human β 2-adrenergic G protein-coupled receptor. Science 2007 318 5854 1258 1265 2-s2.0-36448995359 10.1126/science.1150577 (Pubitemid 350172884)
12. Warne T., Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 2008 7203 486 491
13. Rasmussen S. G. F., Choi H. J., Fung J. J., Pardon E., Casarosa P., Chae P. S., Devree B. T., Rosenbaum D. M., Thian F. S., Kobilka T. S., Schnapp A., Konetzki I., Sunahara R. K., Gellman S. H., Pautsch A., Steyaert J., Weis W. I., Kobilka B. K., Structure of a nanobody-stabilized active state of the β 2 adrenoceptor. Nature 2011 469 7329 175 180 2-s2.0-78651411166 10.1038/nature09648
14. Rasmussen S. G., Crystal structure of the beta 2 adrenergic receptor-Gs protein complex. Nature 2011 477 7366 549 555 10.1038/nature10361
15. Rasmussen S. G., Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007 450 7168 383 387 (Pubitemid 350126755)
16. Dore A. S., Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure 2011 19 9 1283 1293
17. Lebon G., Warne T., Edwards P. C., Bennett K., Langmead C. J., Leslie A. G. W., Tate C. G., Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature 2011 474 7352 521 525 2-s2.0-79959564813 10.1038/nature10136
18. Xu F., Wu H., Katritch V., Han G. W., Jacobson K. A., Gao Z. G., Cherezov V., Stevens R. C., Structure of an agonist-bound human A2A adenosine receptor. Science 2011 332 6027 322 327 2-s2.0-79954782236 10.1126/science.1202793
19. Choe H. W., Kim Y. J., Park J. H., Morizumi T., Pai E. F., Krau N., Hofmann K. P., Scheerer P., Ernst O. P., Crystal structure of metarhodopsin II. Nature 2011 471 7340 651 655 2-s2.0-79953234218 10.1038/nature09789
20. Standfuss J., Edwards P. C., D'Antona A., Fransen M., Xie G., Oprian D. D., Schertler G. F. X., The structural basis of agonist-induced activation in constitutively active rhodopsin. Nature 2011 471 7340 656 660 2-s2.0-79953242234 10.1038/nature09795
21. Scheerer P., Park J. H., Hildebrand P. W., Kim Y. J., Krauß N., Choe H. W., Hofmann K. P., Ernst O. P., Crystal structure of opsin in its G-protein-interacting conformation. Nature 2008 455 7212 497 502 2-s2.0-52949102889 10.1038/nature07330
22. Haga K., Kruse A. C., Asada H., Yurugi-Kobayashi T., Shiroishi M., Zhang C., Weis W. I., Okada T., Kobilka B. K., Haga T., Kobayashi T., Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature 2012 482 7386 547 551 2-s2.0-84857422997 10.1038/nature10753
23. Kruse A. C., Hu J., Pan A. C., Arlow D. H., Rosenbaum D. M., Rosemond E., Green H. F., Liu T., Chae P. S., Dror R. O., Shaw D. E., Weis W. I., Wess J., Kobilka B. K., Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature 2012 482 7386 552 556 2-s2.0-84857396054 10.1038/nature10867
24. Chien E. Y. T., Liu W., Zhao Q., Katritch V., Han G. W., Hanson M. A., Shi L., Newman A. H., Javitch J. A., Cherezov V., Stevens R. C., Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 2010 330 6007 1091 1095 2-s2.0-78449305788 10.1126/science.1197410
25. Hanson M. A., Roth C. B., Jo E., Griffith M. T., Scott F. L., Reinhart G., Desale H., Clemons B., Cahalan S. M., Schuerer S. C., Sanna M. G., Han G. W., Kuhn P., Rosen H., Stevens R. C., Crystal structure of a lipid G protein-coupled receptor. Science 2012 335 6070 851 855 2-s2.0-84857254248 10.1126/science.1215904
26. Shimamura T., Structure of the human histamine H1 receptor complex with doxepin. Nature 2011 475 7354 65 70 10.1038/nature10236
27. Wu B., Chien E. Y. T., Mol C. D., Fenalti G., Liu W., Katritch V., Abagyan R., Brooun A., Wells P., Bi F. C., Hamel D. J., Kuhn P., Handel T. M., Cherezov V., Stevens R. C., Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010 330 6007 1066 1071 2-s2.0-78449292863 10.1126/science.1194396
28. Park J. H., Scheerer P., Hofmann K. P., Choe H. W., Ernst O. P., Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 2008 454 7201 183 187 2-s2.0-47049130668 10.1038/nature07063 (Pubitemid 351969893)
29. Jaakola V. P., Griffith M. T., Hanson M. A., Cherezov V., Chien E. Y. T., Lane J. R., Ijzerman A. P., Stevens R. C., The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 2008 322 5905 1211 1217 2-s2.0-56749103466 10.1126/science.1164772
30. Nygaard R., Frimurer T. M., Holst B., Rosenkilde M. M., Schwartz T. W., Ligand binding and micro-switches in 7tm receptor structures. Trends in Pharmacological Sciences 2009 30 5 249 259 2-s2.0-65449161390 10.1016/j.tips.2009.02.006
31. Mirzadegan T., Benko G., Filipek S., Palczewski K., Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. Biochemistry 2003 42 10 2759 2767 2-s2.0-0037452868 10.1021/bi027224+ (Pubitemid 36331518)
32. Rosenkilde M. M., Benned-Jensen T., Frimurer T. M., Schwartz T. W., The minor binding pocket: a major player in 7tm receptor activation. Trends in Pharmacological Sciences 2010 31 12 567 574 2-s2.0-78549272001 10.1016/j.tips.2010.08.006
33. Benned-Jensen T., Rosenkilde M. M., Structural motifs of importance for the constitutive activity of the orphan 7tm receptor EBI2: analysis of receptor activation in the absence of an agonist. Molecular Pharmacology 2008 74 4 1008 1021 2-s2.0-52949084268 10.1124/mol.108.049676
34. Benned-Jensen T., Rosenkilde M. M., The role of transmembrane segment II in 7tm receptor activation. Current Molecular Pharmacology 2009 2 2 140 148 2-s2.0-77449147872 10.2174/1874467210902020140
35. Schwartz T. W., Sakmar T. P., Structural biology: snapshot of a signalling complex. Nature 2011 477 7366 540 541 2-s2.0-80053370046 10.1038/477540a
36. Ballesteros J. A., Jensen A. D., Liapakis G., Rasmussen S. G. F., Shi L., Gether U., Javitch J. A., Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. Journal of Biological Chemistry 2001 276 31 29171 29177 2-s2.0-0035800850 10.1074/jbc.M103747200
37. Rosenbaum D. M., Zhang C., Lyons J. A., Holl R., Aragao D., Arlow D. H., Rasmussen S. G. F., Choi H. J., Devree B. T., Sunahara R. K., Chae P. S., Gellman S. H., Dror R. O., Shaw D. E., Weis W. I., Caffrey M., Gmeiner P., Kobilka B. K., Structure and function of an irreversible agonist- β 2 adrenoceptor complex. Nature 2011 469 7329 236 240 2-s2.0-78651399683 10.1038/nature09665
38. Springael J. Y., de Poorter C., Deupi X., Van Durme J., Pardo L., Parmentier M., The activation mechanism of chemokine receptor CCR5 involves common structural changes but a different network of interhelical interactions relative to rhodopsin. Cellular Signalling 2007 19 7 1446 1456 2-s2.0-34249332756 10.1016/j.cellsig.2007.01.022 (Pubitemid 46818910)
39. 2-adrenergic receptor establish a barcode that encodes differential functions of β -arrestin. Science Signaling 2011 4 185 ra51 2-s2.0-80051616441 10.1126/scisignal.2001707
40. Rosenkilde M. M., Kledal N., Targeting herpesvirus reliance of the chemokine system. Current Drug Targets 2006 7 1 103 118 2-s2.0-33644889627 10.2174/138945006775270259
41. Rosenkilde M. M., Virus-encoded chemokine receptors-putative novel antiviral drug targets. Neuropharmacology 2005 48 1 1 13 2-s2.0-11144349019 10.1016/j.neuropharm.2004.09.017 (Pubitemid 40022910)
42. Murphy P. M., Viral exploitation and subversion of the immune system through chemokine mimicry. Nature Immunology 2001 2 2 116 122 2-s2.0-0035259780 10.1038/84214 (Pubitemid 33707928)
43. Rosenkilde M. M., Schwartz T. W., Glu VII:06-a highly conserved and selective anchor point for non-peptide ligands in chemokine receptors. Current Topics in Medicinal Chemistry 2006 6 13 1319 1333 2-s2.0-33746658573 (Pubitemid 44144918)
44. Murphy P. M., Baggiolini M., Charo I. F., Hebert C. A., Horuk R., Matsushima K., Miller L. H., Oppenheim J. J., Power C. A., International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacological Reviews 2000 52 1 145 176 2-s2.0-0034092634 (Pubitemid 30127598)
45. Murphy P. M., International union of pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacological Reviews 2002 54 2 227 229 2-s2.0-0036262275 10.1124/pr.54.2.227 (Pubitemid 34575712)
46. Strieter R. M., Polverini P. J., Kunkel S. L., Arenberg D. A., Burdick M. D., Kasper J., Dzuiba J., Van Damme J., Walz A., Marriott D., Chan S. Y., Roczniak S., Shanafelt A. B., The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. Journal of Biological Chemistry 1995 270 45 27348 27357 2-s2.0-20244390429 10.1074/jbc.270.45.27348
47. Rosenkilde M. M., Schwartz T. W., The chemokine system-a major regulator of angiogenesis in health and disease. APMIS 2004 112 7-8 481 495 2-s2.0-10344262597 10.1111/j.1600-0463.2004.apm11207-0808.x (Pubitemid 39626055)
48. Holst P. J., Rosenkilde M. M., Microbiological exploitation of the chemokine system. Microbes and Infection 2003 5 2 179 187 2-s2.0-0037297665 10.1016/S1286-4579(02)00081-3 (Pubitemid 36316060)
49. Neptune E. R., Bourne H. R., Receptors induce chemotaxis by releasing the βγ subunit of Gi, not by activating Gq or Gs. Proceedings of the National Academy of Sciences of the United States of America 1997 94 26 14489 14494 2-s2.0-0031475028
50. Rosenkilde M. M., Waldhoer M., Lüttichau H. R., Schwartz T. W., Virally encoded 7tm receptors. Oncogene 2001 20 13 1582 1593 2-s2.0-0035952635 10.1038/sj.onc.1204191 (Pubitemid 32336846)
51. Choe H., Martin K. A., Farzan M., Sodroski J., Gerard N. P., Gerard C., Structural interactions between chemokine receptors, gp120 Env and CD4. Seminars in Immunology 1998 10 3 249 257 2-s2.0-0032102657 10.1006/smim.1998.0127 (Pubitemid 28347041)
52. Pleskoff O., Tréboute C., Brelot A., Heveker N., Seman M., Alizon M., Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 1997 276 5320 1874 1878 2-s2.0-1842287973 10.1126/science.276.5320.1874 (Pubitemid 27443667)
53. Rosenkilde M. M., Smit M. J., Waldhoer M., Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors. British Journal of Pharmacology 2008 153 supplement 1 S154 S166 2-s2.0-40349096329 10.1038/sj.bjp.0707660 (Pubitemid 351341013)
54. Waldhoer M., Kledal T. N., Farrell H., Schwartz T. W., Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. Journal of Virology 2002 76 16 8161 8168 2-s2.0-0036312026 10.1128/JVI.76.16.8161-8168.2002 (Pubitemid 34809070)
55. Rosenkilde M. M., Kledal T. N., Schwartz T. W., High constitutive activity of a virus-encoded seven transmembrane receptor in the absence of the conserved DRY motif (Asp-Arg-Tyr) in transmembrane helix 3. Molecular Pharmacology 2005 68 1 11 19 2-s2.0-22344450701 10.1124/mol.105.011239 (Pubitemid 41002940)
56. Smit M. J., Verzijl D., Casarosa P., Navis M., Timmerman H., Leurs R., Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor ORF74 constitutively activates p44/p42 MAPK and Akt via Gi and phospholipase C-dependent signaling pathways. Journal of Virology 2002 76 4 1744 1752 2-s2.0-0036146194 10.1128/JVI.76.4.1744-1752.2002 (Pubitemid 34094621)
57. McLean K. A., Holst P. J., Martini L., Schwartz T. W., Rosenkilde M. M., Similar activation of signal transduction pathways by the herpesvirus-encoded chemokine receptors US28 and ORF74. Virology 2004 325 2 241 251 2-s2.0-3142576970 10.1016/j.virol.2004.04.027 (Pubitemid 38902790)
58. Seifert R., Wenzel-Seifert K., Constitutive activity of G-proteins-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 2002 366 5 381 416 2-s2.0-0036033424 10.1007/s00210-002-0588-0 (Pubitemid 35251788)
59. Robbins L. S., Nadeau J. H., Johnson K. R., Kelly M. A., Roselli-Rehfuss L., Baack E., Mountjoy K. G., Cone R. D., Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993 72 6 827 834 2-s2.0-0027413475 10.1016/0092-8674(93)90572-8 (Pubitemid 23110225)
60. Srinivasan S., Lubrano-Berthelier C., Govaerts C., Picard F., Santiago P., Conklin B. R., Vaisse C., Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. Journal of Clinical Investigation 2004 114 8 1158 1164 2-s2.0-9644279627 10.1172/JCI200421927 (Pubitemid 39578705)
61. Pantel J., Legendre M., Cabrol S., Hilal L., Hajaji Y., Morisset S., Nivot S., Vie-Luton M. P., Grouselle D., De Kerdanet M., Kadiri A., Epelbaum J., Le Bouc Y., Amselem S., Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. Journal of Clinical Investigation 2006 116 3 760 768 2-s2.0-33644653308 10.1172/JCI25303 (Pubitemid 43326885)
62. Robinson P. R., Cohen G. B., Zhukovsky E. A., Oprian D. D., Constitutively active mutants of rhodopsin. Neuron 1992 9 4 719 725 2-s2.0-0026661978 10.1016/0896-6273(92)90034-B
63. Rosenkilde M. M., Kledal T. N., Bräuner-Osborne H., Schwartz T. W., Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74. Journal of Biological Chemistry 1999 274 2 956 961 2-s2.0-0033534718 10.1074/jbc.274.2.956 (Pubitemid 29058066)
64. Bais C., Santomasso B., Coso O., Arvanitakis L., Raaka E. G., Gutkind J. S., Asch A. S., Cesarman E., Gerhengorn M. C., Mesri E. A., G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998 391 6662 86 89 2-s2.0-0031937076 10.1038/34193 (Pubitemid 28079220)
65. Sodhi A., Montaner S., Patel V., Zohar M., Bais C., Mesri E. A., Gutkind J. S., The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1 α Cancer Research 2000 60 17 4873 4880 2-s2.0-0034282553
66. Montaner S., Sodhi A., Pece S., Mesri E. A., Gutkind J. S., The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Research 2001 61 6 2641 2648 2-s2.0-0035866812 (Pubitemid 32685850)
67. Montaner S., Sodhi A., Molinolo A., Bugge T. H., Sawai E. T., He Y., Li Y., Ray P. E., Gutkind J. S., Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 2003 3 1 23 36 2-s2.0-0037772150 10.1016/S1535-6108(02)00237-4 (Pubitemid 37443889)
68. Sodhi A., Montaner S., Patel V., Gómez-Román J. J., Li Y., Sausville E. A., Sawait E. T., Gutkind J. S., Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Proceedings of the National Academy of Sciences of the United States of America 2004 101 14 4821 4826 2-s2.0-1842687489 10.1073/pnas.0400835101 (Pubitemid 38469161)
69. Rosenkildel M. M., McLean K. A., Holst P. J., Schwartz T. W., The CXC chemokine receptor encoded by herpesvirus saimiri, ECRF3, shows ligand-regulated signaling through Gi, Gq, and G 12/13 proteins but constitutive signaling only through Gi and G12/13 proteins. Journal of Biological Chemistry 2004 279 31 32524 32533 2-s2.0-3543007121 10.1074/jbc.M313392200 (Pubitemid 39014708)
70. Ahuja S. K., Murphy P. M., Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri. Journal of Biological Chemistry 1993 268 28 20691 20694 2-s2.0-0027372763 (Pubitemid 23292228)
71. Kledal T. N., Rosenkilde M. M., Schwartz T. W., Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28. FEBS Letters 1998 441 2 209 214 2-s2.0-0032431972 10.1016/S0014-5793(98)01551-8 (Pubitemid 29027897)
72. Casarosa P., Gruijthuijsen Y. K., Michel D., Beisser P. S., Holl J., Fitzsimons C. P., Verzijl D., Bruggeman C. A., Mertens T., Leurs R., Vink C., Smit M. J., Constitutive signaling of the human cytomegalovirus-encoded receptor UL33 differs from that of its rat cytomegalovirus homolog R33 by promiscuous activation of G proteins of the Gq, Gi, and Gs classes. Journal of Biological Chemistry 2003 278 50 50010 50023 2-s2.0-10744220558 10.1074/jbc.M306530200 (Pubitemid 37548837)
73. Casarosa P., Bakker R. A., Verzijl D., Navis M., Timmerman H., Leurs R., Smiti M. J., Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28. Journal of Biological Chemistry 2001 276 2 1133 1137 2-s2.0-0035846939 10.1074/jbc.M008965200 (Pubitemid 32096538)
74. Davis-poynter N. J., Lynch D. M., Vally H., Shellam G. R., Rawlinson W. D., Barrell B. G., Farrell H. E., Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus. Journal of Virology 1997 71 2 1521 1529 2-s2.0-0031023157 (Pubitemid 27030328)
75. Beisser P. S., Vink C., van Dam J. G., Grauls G., Vanherle S. J. V., Bruggeman C. A., The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection. Journal of Virology 1998 72 3 2352 2363 2-s2.0-0031913208 (Pubitemid 28100796)
76. Alcami A., Viral mimicry of cytokines, chemokines and their receptors. Nature Reviews Immunology 2003 3 1 36 50 2-s2.0-0037271850 10.1038/nri980 (Pubitemid 37328698)
77. Alcami A., Interaction of viral chemokine inhibitors with chemokines. Methods in Molecular Biology 2004 239 167 180 2-s2.0-2142794637
78. Najarro P., Lee H. J., Fox J., Pease J., Smith G. L., Yaba-like disease virus protein 7L is a cell-surface receptor for chemokine CCL1. Journal of General Virology 2003 84 3325 3336 2-s2.0-0348013163 10.1099/vir.0.19591-0 (Pubitemid 37540760)
79. Najarro P., Gubser C., Hollinshead M., Fox J., Pease J., Smith G. L., Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue. Journal of General Virology 2006 87 809 816 2-s2.0-33645541351 10.1099/vir.0.81427-0
80. Paulsen S. J., Rosenkilde M. M., Eugen-Olsen J., Kledal T. N., Epstein-barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor. Journal of Virology 2005 79 1 536 546 2-s2.0-10644256411 10.1128/JVI.79.1.536-546.2005 (Pubitemid 39648406)
81. Baisser P. S., Verzijl D., Gruijthuijsen Y. K., Beuken E., Smit M. J., Leurs R., Bruggeman C. A., Vink C., The Epstein-Barr virus BILF1 gene encodes a G protein-coupled receptor that inhibits phosphorylation of RNA-dependent protein kinase. Journal of Virology 2005 79 1 441 449 2-s2.0-10644230015 10.1128/JVI.79.1.441-449.2005 (Pubitemid 39648397)
82. Rosenkilde M. M., Benned-Jensen T., Andersen H., Holst P. J., Kledal T. N., Lüttichau H. R., Larsen J. K., Christensen J. P., Schwartz T. W., Molecular pharmacological phenotyping of EBI2: an orphan seven-transmembrane receptor with constitutive activity. Journal of Biological Chemistry 2006 281 19 13199 13208 2-s2.0-33744948051 10.1074/jbc.M602245200 (Pubitemid 43855231)
83. Gether U., Asmar F., Meinild A. K., Rasmussen S. G. F., Structural basis for activation of G-protein-coupled receptors. Pharmacology and Toxicology 2002 91 6 304 312 2-s2.0-0036965731 10.1034/j.1600-0773.2002.910607.x (Pubitemid 36132435)
84. Rasmussen S. G. F., Jensen A. D., Liapakis G., Ghanouni P., Javitch J. A., Gether U., Mutation of a highly conserved aspartic acid in the β 2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. Molecular Pharmacology 1999 56 1 175 184 2-s2.0-0033061256 (Pubitemid 29309827)
85. Oldham W. M., Hamm H. E., Heterotrimeric G protein activation by G-protein-coupled receptors. Nature Reviews Molecular Cell Biology 2008 9 1 60 71 2-s2.0-37549016836 10.1038/nrm2299
86. Lagane B., Ballet S., Planchenault T., Balabanian K., Le Poul E., Blanpain C., Percherancier Y., Staropoli I., Vassart G., Oppermann M., Parmentier M., Bachelerie F., Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis. Molecular Pharmacology 2005 67 6 1966 1976 2-s2.0-21744448695 10.1124/mol.104.009779 (Pubitemid 41007778)
87. Hüttenrauch F., Nitzki A., Lin F. T., Höning S., Oppermann M., β -arrestin binding to CC chemokine receptor 5 requires multiple C-terminal receptor phosphorylation sites and involves a conserved Asp-Arg-Tyr sequence motif. Journal of Biological Chemistry 2002 277 34 30769 30777 2-s2.0-0037163091 10.1074/jbc.M204033200 (Pubitemid 34970774)
88. Schneider E. H., Schnell D., Strasser A., Dove S., Seifert R., Impact of the DRY motif and the missing "ionic lock" on constitutive activity and G-protein coupling of the human histamine H4 receptor. Journal of Pharmacology and Experimental Therapeutics 2010 333 2 382 392 2-s2.0-77951055595 10.1124/jpet.109.163220
89. Takahashi K., Tokita S., Kotani H., Generation and characterization of highly constitutive active histamine H3 receptors. Journal of Pharmacology and Experimental Therapeutics 2003 307 1 213 218 2-s2.0-0141519436 10.1124/jpet.103.053249 (Pubitemid 37151909)
90. Rouleau A., Ligneau X., Tardivel-Lacombe J., Morisset S., Gbahou F., Schwartz J. C., Arrang J. M., Histamine H3-receptor-mediated [35S]GTP γ [S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors. British Journal of Pharmacology 2002 135 2 383 392 2-s2.0-0036008203 (Pubitemid 34151170)
91. Kristiansen K., Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacology and Therapeutics 2004 103 1 21 80 2-s2.0-3042798261 10.1016/j.pharmthera.2004.05.002 (Pubitemid 38891912)
92. Alewijnse A. E., Timmerman H., Jacobs E. H., Smit M. J., Roovers E., Cotecchia S., Leurs R., The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H2 receptor. Molecular Pharmacology 2000 57 5 890 898 2-s2.0-0034112037 (Pubitemid 30253371)
93. Okinaga S., Slattery D., Humbles A., Zsengeller Z., Morteau O., Kinrade M. B., Brodbeck R. M., Krause J. E., Choe H. R., Gerard N. P., Gerard C., C5L2, a nonsignaling C5A binding protein. Biochemistry 2003 42 31 9406 9415 2-s2.0-0041571471 10.1021/bi034489v (Pubitemid 36959248)
94. Peiper S. C., Wang Z. X., Neote K., Martin A. W., Showell H. J., Conklyn M. J., Ogborne K., Hadley T. J., Lu Z. H., Hesselgesser J., Horuk R., The duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of duffy negative individuals who lack the erythrocyte receptor. Journal of Experimental Medicine 1995 181 4 1311 1317 2-s2.0-0028943949 10.1084/jem.181.4.1311
95. Pruenster M., Rot A., Throwing light on DARC. Biochemical Society Transactions 2006 34 1005 1008 2-s2.0-34248671373 10.1042/BST0341005 (Pubitemid 46768977)
96. Nibbs R. J. B., Wylie S. M., Yang J., Landau N. R., Graham G. J., Cloning and characterization of a novel promiscuous human β -chemokine receptor D6. Journal of Biological Chemistry 1997 272 51 32078 32083 2-s2.0-0031434809 10.1074/jbc.272.51.32078 (Pubitemid 28011878)
97. Weber M., Blair E., Simpson C. V., O'Hara M., Blackburn P. E., Rot A., Graham G. J., Nibbs R. J. B., The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Molecular Biology of the Cell 2004 15 5 2492 2508 2-s2.0-2342637779 10.1091/mbc.E03-09- 0634 (Pubitemid 38580663)
98. Holst P. J., Lüttichau H. R., Schwartz T. W., Rosenkilde M. M., Virally encoded chemokines and chemokine receptors in the role of viral infections. Contributions to Microbiology 2003 10 232 252 2-s2.0-0038823731
99. Flanagan C. A., A GPCR that is not 'DRY'. Molecular Pharmacology 2005 68 1 1 3 2-s2.0-22344436511 10.1124/mol.105.014183 (Pubitemid 41002938)
100. Arvanitakis L., Geras-Raaka E., Varma A., Gershengorn M. C., Cesarman E., Human herpesvirus KSHV encodes a constitutively active G-protein- coupled receptor linked to cell proliferation. Nature 1997 385 6614 347 350 2-s2.0-0031032769 10.1038/385347a0 (Pubitemid 27053105)
101. Burger M., Burger J. A., Hoch R. C., Oades Z., Takamori H., Schraufstatter I. U., Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein- coupled receptor. Journal of Immunology 1999 163 4 2017 2022 2-s2.0-0033566677 (Pubitemid 29382205)
102. Rosenkilde M. M., Kledal T. N., Holst P. J., Schwartz T. W., Selective elimination of high constitutive activity or chemokine binding in the human herpesvirus 8 encoded seven transmembrane oncogene ORF74. Journal of Biological Chemistry 2000 275 34 26309 26315 2-s2.0-0034714390 10.1074/jbc.M003800200
103. Wakeling M. N., Roy D. J., Nash A. A., Stewart J. P., Characterization of the murine gammaherpesvirus 68 ORF74 product: a novel oncogenic G protein-coupled receptor. Journal of General Virology 2001 82 1187 1197 2-s2.0-0035022211 (Pubitemid 32454619)
104. Verzijl D., Fitzsimons C. P., Van Dijk M., Stewart J. P., Timmerman H., Smit M. J., Leurs R., Differential activation of murine herpesvirus 68- and Kaposi's sarcoma-associated herpesvirus-encoded ORF74 G protein-coupled receptors by human and murine chemokines. Journal of Virology 2004 78 7 3343 3351 2-s2.0-1842562410 10.1128/JVI.78.7.3343-3351.2004 (Pubitemid 38568275)
105. Isegawa Y., Ping Z., Nakano K., Sugimoto N., Yamanishi K., Human herpesvirus 6 open reading frame U12 encodes a functional β-chemokine receptor. Journal of Virology 1998 72 7 6104 6112 2-s2.0-0031747583 (Pubitemid 28283400)
106. Fitzsimons C. P., Gompels U. A., Verzijl D., Vischer H. F., Mattick C., Leurs R., Smit M. J., Chemokine-directed trafficking of receptor stimulus to different G proteins: selective inducible and constitutive signaling by human herpesvirus 6-encoded chemokine receptor U51. Molecular Pharmacology 2006 69 3 888 898 2-s2.0-33644848660 10.1124/mol.105.015222 (Pubitemid 43363863)
107. Case R., Sharp E., Benned-Jensen T., Rosenkilde M. M., Davis-Poynter N., Farrell H. E., Functional analysis of the murine cytomegalovirus chemokine receptor homologue M33: ablation of constitutive signaling is associated with an attenuated phenotype in vivo. Journal of Virology 2008 82 4 1884 1898 2-s2.0-38949138811 10.1128/JVI.02550-06 (Pubitemid 351222436)
108. Gruijthuijsen Y. K., Beuken E. V. H., Smit M. J., Leurs R., Bruggeman C. A., Vink C., Mutational analysis of the R33-encoded G protein-coupled receptor of rat cytomegalovirus: identification of amino acid residues critical for cellular localization and ligand-independent signalling. Journal of General Virology 2004 85 897 909 2-s2.0-1842843171 10.1099/vir.0.19709-0 (Pubitemid 38489555)
109. Rodems S. M., Spector D. H., Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection. Journal of Virology 1998 72 11 9173 9180 2-s2.0-0031707104 (Pubitemid 28471863)
110. Vomaske J., Melnychuk R. M., Smith P. P., Powell J., Hall L., DeFilippis V., Früh K., Smit M., Schlaepfer D. D., Nelson J. A., Streblow D. N., Differential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility. PLoS Pathogens 2009 5 2 2-s2.0-61449176940 10.1371/journal.ppat.1000304 e1000304
111. Pleskoff O., Casarosa P., Verneuil L., Ainoun F., Beisser P., Smit M., Leurs R., Schneider P., Michelson S., Ameisen J. C., The human cytomegalovirus-encoded chemokine receptor US28 induces caspase-dependent apoptosis. FEBS Journal 2005 272 16 4163 4177 2-s2.0-23844475428 10.1111/j.1742-4658.2005.04829.x (Pubitemid 41160923)
112. Maussang D., Verzijl D., Van Walsum M., Leurs R., Holl J., Pleskoff O., Michel D., Van Dongen G. A. M. S., Smit M. J., Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 2006 103 35 13068 13073 2-s2.0-33748336259 10.1073/pnas.0604433103 (Pubitemid 44338917)
113. Maussang D., Langemeijer E., Fitzsimons C. P., Stigter-van Walsům M., Dijkman R., Borg M. K., Slinger E., Schreiber A., Michel D., Tensen C. P., Van Dongen G. A. M. S., Leurs R., Smit M. J., The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2. Cancer Research 2009 69 7 2861 2869 2-s2.0-66149091169 10.1158/0008-5472.CAN-08-2487
114. Slinger E., Maussang D., Schreiber A., Siderius M., Rahbar A., Fraile-Ramos A., Lira S. A., Söderberg-Nauclér C., Smit M. J., HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Science Signaling 2010 3 133 ra58 2-s2.0-77956635499 10.1126/scisignal.2001180
115. Ranganathan P., Clark P. A., Kuo J. S., Salamat M. S., Kalejta R. F., Significant association of multiple human cytomegalovirus genomic loci with glioblastoma multiforme samples. Journal of Virology 2012 86 2 854 864 2-s2.0-84856836761 10.1128/JVI.06097-11
116. Lucas K. G., Bao L., Bruggeman R., Dunham K., Specht C., The detection of CMV pp65 and IE1 in glioblastoma multiforme. Journal of Neuro-Oncology 2011 103 2 231 238 2-s2.0-79959834313 10.1007/s11060-010-0383-6
117. Cobbs C. S., Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis. Herpesviridae 2011 2 1 10
118. Dziurzynski K., Wei J., Qiao W., Hatiboglu M. A., Kong L. Y., Wu A., Wang Y., Cahill D., Levine N., Prabhu S., Rao G., Sawaya R., Heimberger A. B., Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype. Clinical Cancer Research 2011 17 14 4642 4649 2-s2.0-79960432578 10.1158/1078-0432.CCR-11-0414
119. Lyngaa R., Nørregaard K., Kristensen M., Kubale V., Rosenkilde M. M., Kledal T. N., Cell transformation mediated by the Epstein-Barr virus G
120. Butcher A. J., Prihandoko R., Kong K. C., McWilliams P., Edwards J. M., Bottrill A., Mistry S., Tobin A. B., Differential G-protein-coupled receptor phosphorylation provides evidence for a signaling bar code. Journal of Biological Chemistry 2011 286 13 11506 11518 2-s2.0-79953192547 10.1074/jbc.M110.154526
121. Butcher A. J., Kong K. C., Prihandoko R., Tobin A. B., Physiological role of g-protein coupled receptor phosphorylation. Handbook of Experimental Pharmacology 2012 208 79 94 2-s2.0-84856652508 10.1007/978-3-642-23274-9-5
122. Shenoy S. K., Lefkowitz R. J., Multifaceted roles of β -arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochemical Journal 2003 375 503 515 2-s2.0-0242721361 10.1042/BJ20031076 (Pubitemid 37433499)
123. Shenoy S. K., McDonald P. H., Kohout T. A., Lefkowitz R. J., Regulation of receptor fate by ubiquitination of activated β 2-adrenergic receptor and β -arrestin. Science 2001 294 5545 1307 1313 2-s2.0-0035834428 10.1126/science.1063866 (Pubitemid 33063090)
124. Fraile-Ramos A., Pelchen-Matthews A., Kledal T. N., Browne H., Schwartz T. W., Marsh M., Localization of HCMV UL33 and US27 in endocytic compartments and viral membranes. Traffic 2002 3 3 218 232 2-s2.0-0036112453 10.1034/j.1600-0854.2002.030307.x (Pubitemid 34555479)
125. Berger E. A., HIV entry and tropism: the chemokine receptor connection. AIDS 1997 11 S3 16 2-s2.0-0031298109
126. Fraile-Ramos A., Kledal T. N., Pelchen-Matthews A., Bowers K., Schwartz T. W., Marsh M., The human cytomegalovirus US28 protein is located in endocytic vesicles and undergoes constitutive endocytosis and recycling. Molecular Biology of the Cell 2001 12 6 1737 1749 2-s2.0-0035167651 (Pubitemid 33049726)
127. Fraile-Ramos A., Kohout T. A., Waldhoer M., Marsh M., Endocytosis of the viral chemokine receptor US28 does not require beta-arrestins but is dependent on the clathrin-mediated pathway. Traffic 2003 4 4 243 253 2-s2.0-0038121047 (Pubitemid 36665385)
128. Alkhatib G., Combadiere C., Broder C. C., Feng Y., Kennedy P. E., Murphy P. M., Berger E. A., CC CKR5: a RANTES, MIP-1 α MIP-1 β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996 272 5270 1955 1958 2-s2.0-0030018156 (Pubitemid 26234510)
129. Feng Y., Broder C. C., Kennedy P. E., Berger E. A., HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996 272 5263 872 877 2-s2.0-0030002637 (Pubitemid 26154590)
130. Dong C.-Z., Tian S., Madani N., Choi W.-T., Kumar S., Liu D., Sodroski J. G., Huang Z., An J., Role of CXCR4 internalization in the anti-HIV activity of stromal cell-derived factor-1 α probed by a novel synthetically and modularly modified-chemokine analog. Experimental Biology and Medicine 2011 236 12 1413 1419 2-s2.0-82755172406 10.1258/ebm.2011.011260
131. Signoret N., Oldridge J., Pelchen-Matthews A., Klasse P. J., Tran T., Brass L. F., Rosenkilde M. M., Schwartz T. W., Holmes W., Dallas W., Luther M. A., Wells T. N. C., Hoxie J. A., Marsh M., Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. Journal of Cell Biology 1997 139 3 651 664 2-s2.0-14444272052 10.1083/jcb.139.3.651 (Pubitemid 27485831)
132. Signoret N., Rosenkilde M. M., Klasse P. J., Schwartz T. W., Malim M. H., Hoxie J. A., Marsh M., Differential regulation of CXCR4 and CCR5 endocytosis. Journal of Cell Science 1998 111 2819 2830 2-s2.0-0031754693 (Pubitemid 28479205)
133. Klasse P. J., Rosenkilde M. M., Signoret N., Pelchen-Matthews A., Schwartz T. W., Marsh M., CD4-chemokine receptor hybrids in human immunodeficiency virus type 1 infection. Journal of Virology 1999 73 9 7453 7466 2-s2.0-0032816159 (Pubitemid 29383229)
134. Oppermann M., Mack M., Proudfoot A. E. I., Olbrich H., Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. Journal of Biological Chemistry 1999 274 13 8875 8885 2-s2.0-0033605592 10.1074/jbc.274.13.8875 (Pubitemid 29164688)
135. Aramori I., Zhang J., Ferguson S. S. G., Bieniasz P. D., Cullen B. R., Caron M. G., Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor. The EMBO Journal 1997 16 15 4606 4616 2-s2.0-0030812438 10.1093/emboj/16.15.4606 (Pubitemid 27326598)
136. Kraft K., Olbrich H., Majoul I., Mack M., Proudfoot A., Oppermann M., Characterization of sequence determinants within the carboxyl-terminal domain of chemokine receptor CCR5 that regulate signaling and receptor internalization. Journal of Biological Chemistry 2001 276 37 34408 34418 2-s2.0-0035860777 10.1074/jbc.M102782200
137. Venkatesan S., Petrovic A., Locati M., Kim Y. O., Weissman D., Murphy P. M., A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expression. Journal of Biological Chemistry 2001 276 43 40133 40145 2-s2.0-0035955633 10.1074/jbc.M105722200
138. Orsini M. J., Parent J. L., Mundell S. J., Benovic J. L., Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the C-terminal tail that mediate receptor internalization. Journal of Biological Chemistry 1999 274 43 31076 31086 2-s2.0-0032742818 10.1074/jbc.274.43.31076 (Pubitemid 29503952)
139. Haribabu B., Richardson R. M., Fisher I., Sozzani S., Peiper S. C., Horuk R., Ali H., Snyderman R., Regulation of human chemokine receptors CXCR4: role of phosphorylation in desensitization and internalization. Journal of Biological Chemistry 1997 272 45 28726 28731 2-s2.0-0030712369 10.1074/jbc.272.45.28726 (Pubitemid 27517830)
140. Kawai T., Choi U., Whiting-Theobald N. L., Linton G. F., Brenner S., Sechler J. M. G., Murphy P. M., Malech H. L., Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome. Experimental Hematology 2005 33 4 460 468 2-s2.0-15244361356 10.1016/j.exphem.2005.01.001 (Pubitemid 40387629)
141. Stropes M. P., Schneider O. D., Zagorski W. A., Miller J. L. C., Miller W. E., The carboxy-terminal tail of human cytomegalovirus (HCMV) US28 regulates both chemokine-independent and chemokine-dependent signaling in HCMV-infected cells. Journal of Virology 2009 83 19 10016 10027 2-s2.0-70349276765 10.1128/JVI.00354-09
142. Bodaghi B., Jones T. R., Zipeto D., Vita C., Sun L., Laurent L., Arenzana-Seisdedos F., Virelizier J. L., Michelson S., Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus- infected cells. Journal of Experimental Medicine 1998 188 5 855 866 2-s2.0-0032494168 10.1084/jem.188.5.855 (Pubitemid 28433412)
143. Mokros T., Rehm A., Droese J., Oppermann M., Lipp M., Höpken U. E., Surface expression and endocytosis of the human cytomegalovirus-encoded chemokine receptor US28 is regulated by Agonist-independent phosphorylation. Journal of Biological Chemistry 2002 277 47 45122 45128 2-s2.0-0037160022 10.1074/jbc.M208214200 (Pubitemid 36159114)
144. Waldhoer M., Casarosa P., Rosenkilde M. M., Smit M. J., Leurs R., Whistler J. L., Schwartz T. W., The carboxyl terminus of human cytomegalovirus-encoded 7 transmembrane receptor US28 camouflages agonism by mediating constitutive endocytosis. Journal of Biological Chemistry 2003 278 21 19473 19482 2-s2.0-0038265865 10.1074/jbc.M213179200 (Pubitemid 36799344)
145. Stapleton L. K., Arnolds K. L., Lares A. P., Devito T. M., Spencer J. V., Receptor chimeras demonstrate that the C-terminal domain of the human cytomegalovirus US27 gene product is necessary and sufficient for intracellular receptor localization. Virology Journal 2012 9 1, article 42 2-s2.0-84856852731 10.1186/1743-422X-9-42
146. Liu C., Sandford G., Fei G., Nicholas J., Galpha protein selectivity determinant specified by a viral chemokine receptor-conserved region in the C tail of the human herpesvirus 8 g protein-coupled receptor. Journal of Virology 2004 78 5 2460 2471 2-s2.0-1242342108 10.1128/JVI.78.5.2460-2471.2004 (Pubitemid 38228939)
147. Schwarz M., Murphy P. M., Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF- B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant. Journal of Immunology 2001 167 1 505 513 2-s2.0-0035399819 (Pubitemid 32567818)
148. Verzijl D., Pardo L., Van Dijk M., Gruijthuijsen Y. K., Jongejan A., Timmerman H., Nicholas J., Schwarz M., Murphy P. M., Leurs R., Smit M. J., Helix 8 of the viral chemokine receptor ORF74 directs chemokine binding. Journal of Biological Chemistry 2006 281 46 35327 35335 2-s2.0-33845934719 10.1074/jbc.M606877200 (Pubitemid 46036571)
149. Zuo J., Quinn L. L., Tamblyn J., Thomas W. A., Feederle R., Delecluse H. J., Hislop A. D., Rowe M., The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways. Journal of Virology 2011 85 4 1604 1614 2-s2.0-78951479559 10.1128/JVI.01608-10